VIVEVE MED INC's ticker is VIVE and the CUSIP is 92852W204. A total of 53 filers reported holding VIVEVE MED INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,293,000 | -59.6% | 3,403,402 | 0.0% | 0.89% | -51.6% |
| Q1 2019 | $3,199,000 | -10.9% | 3,403,402 | -0.4% | 1.84% | -41.6% |
| Q4 2018 | $3,589,000 | -65.2% | 3,418,402 | -11.2% | 3.15% | -47.8% |
| Q3 2018 | $10,317,000 | -1.5% | 3,849,711 | 0.0% | 6.03% | -5.2% |
| Q2 2018 | $10,471,000 | -25.7% | 3,849,711 | 0.0% | 6.36% | -15.7% |
| Q1 2018 | $14,090,000 | -26.4% | 3,849,711 | 0.0% | 7.55% | -34.2% |
| Q4 2017 | $19,133,000 | -5.2% | 3,849,711 | 0.0% | 11.47% | -3.6% |
| Q3 2017 | $20,172,000 | -26.7% | 3,849,711 | 0.0% | 11.89% | -20.0% |
| Q2 2017 | $27,513,000 | +13.4% | 3,849,711 | 0.0% | 14.86% | +8.7% |
| Q1 2017 | $24,256,000 | +82.4% | 3,849,711 | +48.1% | 13.67% | +72.6% |
| Q4 2016 | $13,297,000 | -29.2% | 2,599,711 | 0.0% | 7.92% | -48.3% |
| Q3 2016 | $18,770,000 | – | 2,599,711 | – | 15.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,849,711 | $10,471,000 | 6.36% |
| RTW INVESTMENTS, LP | 2,861,023 | $7,782,000 | 0.56% |
| Nantahala Capital Management | 3,948,132 | $10,739,000 | 0.44% |
| Granahan Investment Management | 792,607 | $2,156,000 | 0.13% |
| ACUTA CAPITAL PARTNERS, LLC | 267,500 | $728,000 | 0.13% |
| KNOTT DAVID M | 71,449 | $194,000 | 0.07% |
| WEXFORD CAPITAL LP | 349,100 | $950,000 | 0.06% |
| HighTower Advisors, LLC | 1,821,456 | $4,957,000 | 0.04% |
| MEITAV INVESTMENT HOUSE LTD | 310,000 | $800,000 | 0.04% |
| J. Goldman & Co LP | 221,000 | $601,000 | 0.03% |